# TG Therapeutics, Inc.: Form 8-K, filed Dec 28, 2022

- Company: [TG Therapeutics, Inc.](/companies/tgtx.md) (CIK 1001316)
- Form: 8-K
- Filed: 2022-12-28
- Accepted by EDGAR: Dec 28, 2022, 16:30 ET
- Period: 2022-12-28
- Accession: 0001558370-22-019019
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1001316/000155837022019019/tgtx-20221228x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1001316/000155837022019019/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1001316/000155837022019019/tgtx-20221228x8k.htm

Filed Dec 28, 2022.
Source: SEC EDGAR, the filing index for accession 0001558370-22-019019. Last ingested by Listed: Oct 24, 2026, 15:01 ET. No prices; not investment advice.